Moores Member Receives National Clinical Trials Leadership Award |
Congratulations to Moores Member and breast cancer oncologist Angelique Richardson, MD, PhD for being selected as one of only five recipients of the 2025 Robert A. Winn Excellence in Clinical Trials: Clinical Investigator Leadership Award.
This 3-year award, supported by the Bristol Myers Squibb Foundation and administered by Conquer Cancer and ASCO, recognizes physician-researchers who advance clinical trial leadership and improve access to research for under-resourced communities.
Dr. Richardson expands access to breast cancer clinical trials and reduces disparities in treatment and outcomes, particularly for populations historically underrepresented in cancer research. Learn More>>
|
|
|
AI Enables Rapid Identification of Targeted Cancer Therapy |
A recently published study led by Moores Members Scott M. Lippman, MD, Ludmil B. Alexandrov, PhD, with Erik N. Bergstrom, PhD has developed DeepHRD — an AI tool that detects a key cancer biomarker from routine biopsy images and delivers fast, accurate results, which bypasses the need for genomic sequencing so that oncologists can start targeted treatment sooner. Learn More>>
|
|
|
Investigating the Effect of Space Radiation on Cancer Development
|
Director of the Moores Biobehavioral Shared Resource, Brinda K. Rana, PhD, was featured in The Week for her research on physiological changes in astronauts, which includes cancer risk from space radiation. Her results provide new potential directions for interdisciplinary research and funding. Learn More>>
|
|
|
2nd Annual UC San Diego Gene Therapy Initiative Symposium
|
On Thursday, September 18, 2025, all gene therapy researchers are encouraged to attend this symposium at the Salk Institute, which will (1) provide opportunities for poster presentations and networking with experts in academia and industry and (2) address gene therapy tools and applications, safety considerations, and emerging biotech. Learn More>>
|
|
|
| Rewired m6A of promoter antisense RNAs in Alzheimer's disease regulates neuronal genes in 3D nucleome
|
Sheng Zhong, PhD (Structural and Functional Genomics)
|
|
|
|
Hepatic glycogen directly regulates gluconeogenesis through an AMPK/CRTC2 axis in mice
|
The Journal of Clinical Investigation
|
Alan R. Saltiel, PhD (Cancer Biology and Signaling)
|
|
|
| Genome-Wide CRISPR Screening Reveals that mTOR Inhibition Initiates Ferritinophagy and Ferroptosis in Head and Neck Cancer
|
Alfredo A. Molinolo, MD, PhD (Solid Tumor Therapeutics [STT]), Edward A. Dennis, PhD (STT), Prashant Mali, PhD (Cancer Biology and Signaling [CBS]), and J. Silvio Gutkind, PhD (CBS)
|
|
|
The Researcher Spotlight is designed to help you connect with fellow researchers, gain insights into their diverse projects, and discover the paths that led them to their current roles. Uncover a personal touch to their professional achievements, showcasing the varied perspectives within our cancer research community.
|
Haydee Ojeda-Fournier, MD, is a board-certified radiologist. She specializes in breast imaging and the detection of breast cancer utilizing mammography, sonography, molecular breast imaging and magnetic resonance imaging (MRI). Additionally, she is the inaugural Grillo-Marxuach Family Endowed Medical Director in Breast Imaging at UC San Diego Health.
|
|
|
CLINICAL TRIALS OFFICE (CTO)
|
UCSD 812728: sIND: N803 in treatment refractory metastatic chromophobe renal cell carcinoma (SP259)
PI: Rana McKay, MD
NCT ID: Not in CT.gov
AUTO1-OS1: Expanded Access Program (EAP) for Obecabtagene Autoleucel (obecel) Out-of-specification (OOS) in Adult Patients with Acute Lymphoblastic Leukemia
PI: Dimitrios Tzachanis, MD, PhD
NCT ID: NCT06799221
UCSD 812774: sIND: Single Patient Expanded Access of Donor-Derived AntiCD33 Chimeric Antigen Receptor Expressing T Cells (VCAR33) for 65YearOld Patient TTG
PI: Divya Koura, MD
NCT ID: Not in CT.gov
CTIU2317-A082304-S2402: Perioperative Versus Adjuvant Systemic Therapy in Patients With Resectable Non-Small Cell Lung Cancer PROSPECT LUNG
PI: Lyudmila Bazhenova, MD
NCT ID: NCT06632327
|
|
|
|
